COVID-19 vaccine study that was blocked from CDC journal is published elsewhere

NEW YORK (AP) — A study on COVID-19 vaccine effectiveness has finally been published after being blocked from a government health journal.

The vaccine was found to be about 55% effective against COVID-19-associated hospitalizations, and reduced COVID-19-related trips to emergency departments and urgent care clinics by 50%, according to the study published Tuesday by JAMA Network Open. The findings are not particularly surprising: Researchers have repeatedly found that COVID-19 vaccines work. But the paper drew public attention after Trump administration political appointees decided not to run it in a Centers for Disease Control and Prevention publication.

They argued that the study’s design was too vulnerable to false assumptions that could produce flawed results. But many public health researchers maintain it’s a reliable design that’s been used for decades and offers the best way to understand how well a vaccine is working currently. . . . . .

But the panel also included one critic: Martin Kulldorff, a Swedish-born biostatistician who — along with Bhattacharya — was a co-author of the Great Barrington Declaration, an October 2020 letter maintaining that pandemic shutdowns were causing irreparable harm.

U.S. Health Secretary Robert F. Kennedy Jr. last year appointed Kulldorff as head of a federal vaccine advisory committee before the biostatistician stepped down to become chief science officer at the HHS planning and evaluation office.

Kulldorff argued that studies with that design can — but shouldn’t — include people with different diseases. He also questioned why longer-term studies weren’t used to evaluate COVID-19 vaccines.

Message from Jim Robinson:

Dear FRiends,

We need your continuing support to keep FR funded. Your donations are our sole source of funding. No sugar daddies, no advertisers, no paid memberships, no commercial sales, no gimmicks, no tax subsidies. No spam, no pop-ups, no ad trackers.

If you enjoy using FR and agree it's a worthwhile endeavor, please consider making a contribution today:

Click here: to donate by Credit Card

Or here: to donate by PayPal

Or by mail to: Free Republic, LLC - PO Box 9771 - Fresno, CA 93794

Thank you very much and God bless you,

Jim

“The vaccine was found to be about 55% effective against COVID-19-associated hospitalizations, and reduced COVID-19-related trips to emergency departments and urgent care clinics by 50%, according to the study published Tuesday by JAMA Network Open.”

Well, most of those who died after receiving the ‘vaccine’ did so within the first 3 days. THe first month had marked elevation of deaths by those who received the vaccine. In many cases, family members were found lying on the floor at home, or dead in their beds. This reduced Covid related hospitalizations significantly.
During the Plandemic I suspect many hoped against hope that it worked, and stayed out of the hospitals as they struggled with adverse events related to the ‘vax’ because by then the public knew the CDC’s required Covid Protocol for hospitals was deadly, they could be denied visits from family or forcibly detained as walking contaigons.

It’s sick to read this revisionist history claiming some sort of efficacy. The Covid ‘test’ in use during the Plandemic was not based on the Covid virus. The test was based on a ‘related virus’, according to the CDC. However, Fauci said Covid was a ‘novel virus’ (classification) and that our immune systems had never encountered related viruses as it was ‘new’. The lies, lies lies are still around, ‘modifying’ a purported ‘98% efficacy’ falsely based on relative reductions (RR) instead of absolute reductions in illness to become 50 something percent efficacy. It’s toxic and there is no upside to getting the Covid vax.

Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.